Evidence map›Paper›PMID 34437092›Full record

ArticleScience (New York, N.Y.)2021

Revealing enzyme functional architecture via high-throughput microfluidic enzyme kinetics.

C J Markin, D A Mokhtari, F Sunden, M J Appel, E Akiva, S A Longwell, C Sabatti, D Herschlag, P M Fordyce

Open access · greenAbstract read
In one paragraph

Article in Science (New York, N.Y.), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 117 papers.

0numbers the graph read from it
0cells of the map it votes in
117citing papers in PubMed
13.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

117 citing papers in PubMed, 223 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Amplicon/Protein Bead Display enables quantitativebioRxiv : the preprint server for biology · 2026
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Fold-Switching Proteins.Annual review of biophysics · 2026
    Review
  16. Article
  17. Article
  18. Determinants of metal import and specificity in a bacterial transporter.bioRxiv : the preprint server for biology · 2026
    Article
  19. Article
  20. Article

57 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

C J Markin *Department of Biochemistry, Stanford University, Stanford, CA 94305, USA.ORCID 0000-0002-2147-0744
D A Mokhtari *Department of Biochemistry, Stanford University, Stanford, CA 94305, USA.ORCID 0000-0003-4206-9471
F SundenDepartment of Biochemistry, Stanford University, Stanford, CA 94305, USA.ORCID 0000-0003-4110-7384
M J AppelDepartment of Biochemistry, Stanford University, Stanford, CA 94305, USA.ORCID 0000-0001-7501-8115
E AkivaDepartment of Bioengineering and Therapeutic Sciences, University of California, San Francisco, CA 94158, USA.
S A LongwellDepartment of Bioengineering, Stanford University, Stanford, CA 94305, USA.ORCID 0000-0003-4064-0400
C SabattiDepartment of Biomedical Data Science, Stanford University, Stanford, CA 94305, USA.ORCID 0000-0001-5829-9058
D HerschlagDepartment of Biochemistry, Stanford University, Stanford, CA 94305, USA. herschla@stanford.edu pfordyce@stanford.edu.ORCID 0000-0002-4685-1973
P M FordyceDepartment of Bioengineering, Stanford University, Stanford, CA 94305, USA. herschla@stanford.edu pfordyce@stanford.edu.ORCID 0000-0002-9505-0638
Stanford University · USChan Zuckerberg Initiative (United States) · USUniversity of California, San Francisco · US

Funding

Study of Nonenzymatic and Enzymatic Phosphoryl TransferR01GM064798 · NIGMS · STANFORD UNIVERSITY · PI Polly Morrell Fordyce, DANIEL HERSCHLAG · 2002 to 2026
$5.9M
NIGMS NIH HHS R01 GM064798
6 · The paper itself

Abstract

Systematic and extensive investigation of enzymes is needed to understand their extraordinary efficiency and meet current challenges in medicine and engineering. We present HT-MEK (High-Throughput Microfluidic Enzyme Kinetics), a microfluidic platform for high-throughput expression, purification, and characterization of more than 1500 enzyme variants per experiment. For 1036 mutants of the alkaline phosphatase PafA (phosphate-irrepressible alkaline phosphatase of Flavobacterium), we performed more than 670,000 reactions and determined more than 5000 kinetic and physical constants for multiple substrates and inhibitors. We uncovered extensive kinetic partitioning to a misfolded state and isolated catalytic effects, revealing spatially contiguous regions of residues linked to particular aspects of function. Regions included active-site proximal residues but extended to the enzyme surface, providing a map of underlying architecture not possible to derive from existing approaches. HT-MEK has applications that range from understanding molecular mechanisms to medicine, engineering, and design.

Indexed as

Alkaline PhosphataseBiocatalysisCatalytic DomainFlavobacteriumHydrolysisKineticsMicrofluidicsModels, MolecularMutationOxygenPhosphatesProtein ConformationProtein FoldingThermodynamicsAlkaline PhosphataseOxygenPhosphates

Identifiers

PMID34437092
PMCPMC8454890
OpenAlexW3108171657

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.